NBME PHARM SHELF EXAM
QUESTIONS WITH CORRECT VERIFIED
DETAILED ANSWERS UPDATED
Introduction:
This document contains a complete collection of NBME Pharmacology Shelf exam
questions with verified and detailed answers, updated for 2025. It covers key
pharmacological mechanisms, therapeutic uses, adverse effects, antidotes, and
drug interactions across major drug classes. The material also includes treatment
guidelines, drug reactions, teratogenic effects, and high-yield mnemonics for
exam preparation. It is designed as a comprehensive study aid for medical
students preparing for the NBME Pharmacology Shelf exam.
Autonomic Nervous System Pharmacology
1: What is the mechanism of action of beta-blockers in treating hypertension?
--- -CORRECT ANSWER>>--- Beta-blockers work by blocking beta-adrenergic
receptors, which reduces heart rate and cardiac output, ultimately lowering
blood pressure. They also decrease renin release from the kidneys, further
contributing to antihypertensive effects.
2: A patient receiving a beta-blocker develops bronchospasm. Which receptor
blockade is responsible?
--- -CORRECT ANSWER>>--- Blockade of beta-2 adrenergic receptors in the
bronchial smooth muscle. Beta-1 selective agents are less likely to cause this, but
at high doses, selectivity is lost.
3: What is the mechanism of action of prazosin, and what is its major dose-
limiting adverse effect?
--- -CORRECT ANSWER>>--- Prazosin is a selective alpha-1 antagonist that causes
,vasodilation. The major dose-limiting adverse effect is first-dose orthostatic
hypotension, which can cause syncope.
4: A patient accidentally receives an intravenous dose of epinephrine instead of
phenylephrine. Which receptor activation explains the resulting tachycardia?
--- -CORRECT ANSWER>>--- Epinephrine activates beta-1 adrenergic receptors in
the heart, increasing heart rate and contractility. Phenylephrine is a selective
alpha-1 agonist and would not cause this effect.
5: Which adrenergic receptor is primarily responsible for mediating
vasoconstriction?
--- -CORRECT ANSWER>>--- Alpha-1 adrenergic receptors on vascular smooth
muscle. Activation leads to increased intracellular calcium and smooth muscle
contraction.
6: What is the primary mechanism of action of clonidine in treating hypertension?
--- -CORRECT ANSWER>>--- Clonidine is an alpha-2 adrenergic agonist that acts
centrally in the brainstem to reduce sympathetic outflow. This decreases
peripheral vascular resistance and heart rate.
7: A patient on clonidine abruptly stops taking the medication and develops
severe rebound hypertension. What is the mechanism?
--- -CORRECT ANSWER>>--- Abrupt cessation leads to unopposed sympathetic
activity due to downregulation of feedback inhibition. This causes a surge in
catecholamine release.
8: What is the mechanism of action of atropine, and what is its primary clinical
use?
--- -CORRECT ANSWER>>--- Atropine is a muscarinic receptor antagonist that
blocks the effects of acetylcholine. Its primary use is to increase heart rate in
symptomatic bradycardia.
9: A patient receiving atropine develops blurred vision, dry mouth, and urinary
retention. What is the mechanism of these effects?
--- -CORRECT ANSWER>>--- These are anticholinergic effects resulting from
blockade of muscarinic receptors in the eye (cycloplegia/mydriasis), salivary
glands, and bladder detrusor muscle.
, 10: Neostigmine is used to treat myasthenia gravis. What is its mechanism of
action?
--- -CORRECT ANSWER>>--- Neostigmine is an acetylcholinesterase inhibitor that
increases the concentration of acetylcholine at the neuromuscular junction. This
improves muscle contraction.
11: Why is neostigmine preferred over edrophonium for chronic treatment of
myasthenia gravis?
--- -CORRECT ANSWER>>--- Neostigmine has a longer duration of action, making
it suitable for maintenance therapy. Edrophonium is ultra-short-acting and used
for diagnostic purposes.
12: What is the mechanism of action of succinylcholine, and why does it cause
fasciculations before paralysis?
--- -CORRECT ANSWER>>--- Succinylcholine is a depolarizing neuromuscular
blocker that acts as an acetylcholine agonist at nicotinic receptors. Initial
depolarization causes transient fasciculations before persistent depolarization
leads to paralysis.
13: A patient with pseudocholinesterase deficiency receives succinylcholine and
experiences prolonged paralysis. What is the mechanism?
--- -CORRECT ANSWER>>--- Succinylcholine is normally rapidly hydrolyzed by
plasma pseudocholinesterase. Deficiency leads to delayed metabolism and
prolonged neuromuscular blockade.
14: What is the antidote for rocuronium-induced neuromuscular blockade?
--- -CORRECT ANSWER>>--- Sugammadex is a selective relaxant binding agent
that encapsulates rocuronium, reversing its effects. It is also effective for
vecuronium.
15: How does glycopyrrolate differ from atropine in its clinical use?
--- -CORRECT ANSWER>>--- Glycopyrrolate is a quaternary ammonium
anticholinergic that does not cross the blood-brain barrier. It is used
preoperatively to reduce secretions without causing central anticholinergic
effects.
16: Phenylephrine is used to treat hypotension during spinal anesthesia. What is
its mechanism?
QUESTIONS WITH CORRECT VERIFIED
DETAILED ANSWERS UPDATED
Introduction:
This document contains a complete collection of NBME Pharmacology Shelf exam
questions with verified and detailed answers, updated for 2025. It covers key
pharmacological mechanisms, therapeutic uses, adverse effects, antidotes, and
drug interactions across major drug classes. The material also includes treatment
guidelines, drug reactions, teratogenic effects, and high-yield mnemonics for
exam preparation. It is designed as a comprehensive study aid for medical
students preparing for the NBME Pharmacology Shelf exam.
Autonomic Nervous System Pharmacology
1: What is the mechanism of action of beta-blockers in treating hypertension?
--- -CORRECT ANSWER>>--- Beta-blockers work by blocking beta-adrenergic
receptors, which reduces heart rate and cardiac output, ultimately lowering
blood pressure. They also decrease renin release from the kidneys, further
contributing to antihypertensive effects.
2: A patient receiving a beta-blocker develops bronchospasm. Which receptor
blockade is responsible?
--- -CORRECT ANSWER>>--- Blockade of beta-2 adrenergic receptors in the
bronchial smooth muscle. Beta-1 selective agents are less likely to cause this, but
at high doses, selectivity is lost.
3: What is the mechanism of action of prazosin, and what is its major dose-
limiting adverse effect?
--- -CORRECT ANSWER>>--- Prazosin is a selective alpha-1 antagonist that causes
,vasodilation. The major dose-limiting adverse effect is first-dose orthostatic
hypotension, which can cause syncope.
4: A patient accidentally receives an intravenous dose of epinephrine instead of
phenylephrine. Which receptor activation explains the resulting tachycardia?
--- -CORRECT ANSWER>>--- Epinephrine activates beta-1 adrenergic receptors in
the heart, increasing heart rate and contractility. Phenylephrine is a selective
alpha-1 agonist and would not cause this effect.
5: Which adrenergic receptor is primarily responsible for mediating
vasoconstriction?
--- -CORRECT ANSWER>>--- Alpha-1 adrenergic receptors on vascular smooth
muscle. Activation leads to increased intracellular calcium and smooth muscle
contraction.
6: What is the primary mechanism of action of clonidine in treating hypertension?
--- -CORRECT ANSWER>>--- Clonidine is an alpha-2 adrenergic agonist that acts
centrally in the brainstem to reduce sympathetic outflow. This decreases
peripheral vascular resistance and heart rate.
7: A patient on clonidine abruptly stops taking the medication and develops
severe rebound hypertension. What is the mechanism?
--- -CORRECT ANSWER>>--- Abrupt cessation leads to unopposed sympathetic
activity due to downregulation of feedback inhibition. This causes a surge in
catecholamine release.
8: What is the mechanism of action of atropine, and what is its primary clinical
use?
--- -CORRECT ANSWER>>--- Atropine is a muscarinic receptor antagonist that
blocks the effects of acetylcholine. Its primary use is to increase heart rate in
symptomatic bradycardia.
9: A patient receiving atropine develops blurred vision, dry mouth, and urinary
retention. What is the mechanism of these effects?
--- -CORRECT ANSWER>>--- These are anticholinergic effects resulting from
blockade of muscarinic receptors in the eye (cycloplegia/mydriasis), salivary
glands, and bladder detrusor muscle.
, 10: Neostigmine is used to treat myasthenia gravis. What is its mechanism of
action?
--- -CORRECT ANSWER>>--- Neostigmine is an acetylcholinesterase inhibitor that
increases the concentration of acetylcholine at the neuromuscular junction. This
improves muscle contraction.
11: Why is neostigmine preferred over edrophonium for chronic treatment of
myasthenia gravis?
--- -CORRECT ANSWER>>--- Neostigmine has a longer duration of action, making
it suitable for maintenance therapy. Edrophonium is ultra-short-acting and used
for diagnostic purposes.
12: What is the mechanism of action of succinylcholine, and why does it cause
fasciculations before paralysis?
--- -CORRECT ANSWER>>--- Succinylcholine is a depolarizing neuromuscular
blocker that acts as an acetylcholine agonist at nicotinic receptors. Initial
depolarization causes transient fasciculations before persistent depolarization
leads to paralysis.
13: A patient with pseudocholinesterase deficiency receives succinylcholine and
experiences prolonged paralysis. What is the mechanism?
--- -CORRECT ANSWER>>--- Succinylcholine is normally rapidly hydrolyzed by
plasma pseudocholinesterase. Deficiency leads to delayed metabolism and
prolonged neuromuscular blockade.
14: What is the antidote for rocuronium-induced neuromuscular blockade?
--- -CORRECT ANSWER>>--- Sugammadex is a selective relaxant binding agent
that encapsulates rocuronium, reversing its effects. It is also effective for
vecuronium.
15: How does glycopyrrolate differ from atropine in its clinical use?
--- -CORRECT ANSWER>>--- Glycopyrrolate is a quaternary ammonium
anticholinergic that does not cross the blood-brain barrier. It is used
preoperatively to reduce secretions without causing central anticholinergic
effects.
16: Phenylephrine is used to treat hypotension during spinal anesthesia. What is
its mechanism?
